The University of Chicago Header Logo

Connection

Jiong Zhao to Drug Synergism

Back to Details
This is a "connection" page, showing publications Jiong Zhao has written about Drug Synergism.
Jiong Zhao
Connection Strength
0.043
Drug Synergism
  1. XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer. Proc Natl Acad Sci U S A. 2022 01 25; 119(4).
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.